Oddity Tech: No Fundamental Weakness Seen; I Reiterate Buy
Summarize this article with:
May Investing Ideas701 FollowersFollow5ShareSavePlay(8min)CommentsSummaryOddity Tech is recommended as a buy, with the platform thesis now materially de-risked by MethodIQ's launch and international scaling.MethodIQ and ODDITY Labs transform ODD into a defensible technology platform, offering proprietary molecules and higher efficacy in the $27B acne and dermatology market.International revenue is growing ~40% year-to-date, validating ODD’s scalable, language-agnostic tech stack and reducing US concentration risk.Despite strong Q3 results and improved fundamentals, ODD trades at a compressed 17.6x forward P/E, creating an attractive disconnect for investors. Maskot/DigitalVision via Getty Images Investment overview I wrote about Oddity Tech (ODD) previously with a buy rating, as I saw a strong growth runway ahead, one that is backed by a deep moat and a growing international footprint. Since my last write-up, the ODD equityThis article was written byMay Investing Ideas701 FollowersFollowI am an individual investor that is now fully focus on managing my own capital that I have saved up over the years. My investing background spreads across a wide spectrum as I believe there are merits to each approach, for instance: Fundamental investing [Bottoms-up etc.], Technical investing [historical charts analysis], and to some extend momentum investing [share price reaction post earnings etc.]. Over the years, I have used the positive aspects of each approach to hone my investing process. The reason to write on SeekingAlpha is to use this platform as a tracker for my investing ideas performance, and also to connect with like-minded investors that have the same investing interest.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.